VanEck Vectors Profile

124.08
USD 5.13  3.97%

VanEck Vectors Biotech Risk Profiles

VanEck Vectors Key Fundamentals

VanEck Vectors Against Markets

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. VanEck Vectors is traded on NASDAQ General Markets in USA. more
NameVanEck Vectors Biotech ETF
ChairmanPhilip HornigView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionGlobal
Investment IssuerVan Eck
ExchangeNASDAQ General Markets
Etf FamilyVanEck
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone800 826 2333
CurrencyUSD - US Dollar
IssuerVan Eck
DescriptionVanEck Vectors Biotech ETF
Inception Date2011-12-20
BenchmarkMV US Listed Biotech 25 NR USD
Entity TypeRegulated Investment Company
Asset Under Management452.6 Million
Average Trading Valume18,625
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionGlobal
AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Portfolio ManagerHao-Hung (Peter) Liao, Guo Hua (Jason) Jin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year EndSeptember 30
ExchangeThe NASDAQ Stock Market LLC
Number of Constituents25.0
Market MakerVirtu Financial
Total Expense0.39
Management Fee0.35
Nav Price124.19
Two Hundred Day Average125.06
Ytd15.40%
Average Daily Volume In Three Month28.31k
Fifty Two Week Low103.25
Average Daily Volume Last 10 Day14.88k
Fifty Two Week High136.84
One Month15.40%
Fifty Day Average120.5
Three Month7.39%
Beta In Three Year1.38
Check also Trending Equities. Please also try Theme Ratings module to determine theme ratings based on digital equity recommendations. macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com